About Us

“When my father, Dr. Gabriele Braglia, founded Helsinn in 1976, he had a simple pharmaceutical licensing business in mind. Now, over 40 years later, we’ve grown to over 600 committed employees, and around 70 commercial and marketing partners, that are helping us create a large portfolio of cancer-care therapies. As we move forward, we will never forget our fundamental objective: to build better todays for every person affected by cancer.” Riccardo Braglia, Helsinn Group Vice Chairman and CEO